Interview: Ahmed Zaghloul – President, Egypt Otsuka
Japanese company Otsuka envisioned Egypt as a hub for its Middle East and African operations as early as 1995. The president of the local subsidiary discusses the current activities of…
Egypt Otsuka was established in 10th of Ramadan City in 1992 aiming to supply Otsuka’s pharmaceutical products in the Egyptian market and succeeded to the business of Arab Otsuka Pharmaceutical Co., S.A.E. established in the Public Free Zone (special tax free zone for export) in Cairo in 1977. Since then, Egypt Otsuka has been engaged in manufacturing and distributing intravenous infusions and therapeutic drugs in Egypt and neighbouring countries in the Middle East as well as in Africa. Along with growing demands for intravenous infusion products in those markets, Egypt Otsuka’s production capacity has nearly reached a maximum level and its expansion has been an immediate task to meet the growing demand.
In June of 2014, acquired 80% of Ateco Pharma Egypt, an Egyptian intravenous infusion manufacturing company and has a large domestic market share. This acquisition enabled Egypt Otsuka to expand its annual production capacity of intravenous infusions by approximately 50% in volume and sufficiently meet the increasing demands in the market. Ateco Pharma Egypt was renamed as “Otsuka Ateco Pharma Egypt” following the acquisition.
Contact
ar El-Sadik St, off Dr. Abdallah El-Araby street (Tayaran), Nasr City, 11759 Cairo
Phone: 20 201 536 9561
Fax: 20 201 536 9564
Japanese company Otsuka envisioned Egypt as a hub for its Middle East and African operations as early as 1995. The president of the local subsidiary discusses the current activities of…
General manager of MEA, Khaled Elrefae, explains how Ipsen has strengthened its footprint in the region over the past two years – starting in the UAE and expanding into Saudi…
Building on a stellar career in pharma and medtech both in Egypt and internationally, Ahmed Ezz El-Din now serves as CEO of Cleopatra Hospitals Group, Egypt’s largest private hospital provider.…
While evidence and recognition are growing that gender-balanced and diverse management teams at all levels of hierarchies produce positive business outcomes, the MENA region still has a long road to…
Bristol Myers Squibb’s Oscar Delgado outlines the firm’s successes in bringing innovative medicines to the Middle East and Africa in recent years, how its strategy plays out in an economically…
While universal health insurance is the talk of the town in Egypt today, private healthcare groups – serving up to 40 percent of the population in both the insurance and…
Based in Egypt, Medtronic Africa’s regional vice president, Eman Ali, speaks about the challenges of building a strategic roadmap and local capabilities for the entire African continent from the ground…
First founded in 2019 as a new regulatory body independent from Egypt’s Ministry of Health, the Egyptian Drug Authority (EDA) has made significant progress over the last three years. Now…
Neeraj Mishra of Alameda Healthcare, the largest private healthcare organisation in Egypt, outlines the organisation’s strategy for Egypt and Africa, how – as a provider of private hospitals – it…
The COVID-19 pandemic and the subsequent struggle to obtain vaccines shone a harsh light on Africa’s reliance on pharma exports. As a McKinsey study notes, there were only around 375…
AbbVie’s GM for Egypt & Levant, Ali Sleiman, explains the factors behind the stellar growth that has made the cluster one of the company’s fastest-growing global markets in 2021. He…
With over 100 years of pharmaceutical industry heritage behind it, EVA Pharma has expanded rapidly in recent years, with a CAGR of 24.39 percent over the last three years, propelling…
After several years abroad, Mohamed Eldababy recently returned to his home country to become GSK Egypt’s General Manager. Egypt is an important market for GSK as one of the largest…
See our Cookie Privacy Policy Here
